enfortumab vedotin

E2049901 UNEXPLORED

Enfortumab vedotin is an antibody-drug conjugate used primarily to treat advanced urothelial (bladder) cancer by delivering a cytotoxic agent directly to cancer cells expressing Nectin-4.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
enfortumab vedotin canonical	2

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Seagen → hasTherapy → enfortumab vedotin ⓘ

Seagen → developed → enfortumab vedotin ⓘ